Prostaglandin E1 for renal function preservation in transplant patients -: No further trials required?

被引：2

作者：

Candela-Toha, AM

Martinez-Pérez, A

Liaño, F

机构：

[1] Univ Alcala de Henares, Hosp Ramon y Cajal, Dept Anesthesia, Madrid 28034, Spain

[2] Univ Alcala de Henares, Hosp Ramon y Cajal, Serv Nephrol, Liver Transplantat Unit, Madrid 28034, Spain

来源：

TRANSPLANTATION | 1999年 / 68卷 / 01期

关键词：

D O I：

10.1097/00007890-199907150-00034

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 [免疫学];

摘要：

引用

页码：166 / 166

页数：1

共 5 条

[1]

Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation [J].

Brown, RS ;

Lombardero, M ;

Lake, JR .

TRANSPLANTATION, 1996, 62 (12) :1788-1793

[2]

Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation [J].

Fraley, DS ;

Burr, R ;

Bernardini, J ;

Angus, D ;

Kramer, DJ ;

Johnson, JP .

KIDNEY INTERNATIONAL, 1998, 54 (02) :518-524

[3]

HENLEY KS, 1995, HEPATOLOGY, V21, P366, DOI 10.1016/0270-9139(95)90094-2

[4]

Prostaglandin E(1) administration following orthotopic liver transplantation: A randomized prospective multicenter trial [J].

Klein, AS ;

Cofer, JB ;

Pruett, TL ;

Thuluvath, PJ ;

McGory, R ;

Uber, L ;

Stevenson, WC ;

Baliga, P ;

Burdick, JF .

GASTROENTEROLOGY, 1996, 111 (03) :710-715

[5]

Prostaglandin E1 analogs do not improve renal function among either transplant or nontransplant patients -: No further trials required [J].

Ray, JG .

TRANSPLANTATION, 1998, 66 (04) :476-483

← 1 →